Skip to main content
SearchLogin or Signup

Reviews of "Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19"

Reviewers: Susanna Hofmann (Helmholtz Diabetes Center) | 📗📗📗📗◻️ • L Marie (Albert Einstein Medical Center) | 📒📒📒◻️◻️

Published onOct 16, 2020
Reviews of "Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19"
history

You're viewing an older Release (#1) of this Pub.

  • This Release (#1) was created on Oct 16, 2020 ()
  • The latest Release (#2) was created on Jan 11, 2021 ().

To read the original manuscript, click the link above. To read the reviews, click the links below.

Comments
0
comment

No comments here